Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study
Sign Up to like & getrecommendations! Published in 2025 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.70095
Abstract: Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.… read more here.
Keywords: rituximab refractoriness; aqp4 igg; factors rituximab; refractoriness aqp4 ... See more keywords